BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25546919)

  • 1. Astrocytoma malignum in glioblastoma multiforme vertens with long term survival--case report and a literature review.
    Bochenek-Cibor J; Krupa M; Moskała M; Trojanowski T
    Przegl Lek; 2014; 71(8):454-5. PubMed ID: 25546919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant astrocytic gliomas in children.
    Marchese MJ; Chang CH
    Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide.
    Kuo LT; Tsai SY; Yang CY; Lin LW
    Asian J Surg; 2017 Jan; 40(1):61-65. PubMed ID: 23978432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar glioblastoma multiforme in an adult woman.
    Sciacero P; Girelli GF; Cante D; Franco P; Casanova Borca V; Grosso P; Marra A; Bombaci S; Tofani S; La Porta MR; Ricardi U
    Tumori; 2014; 100(3):e74-8. PubMed ID: 25076255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
    Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of adult onset medulloblastoma during maintenance chemotherapy for anaplastic astrocytoma one year after radiotherapy.
    Takeshi N; Kazuhiko S; Koji I; Toshikazu H; Kaoru K
    Turk Neurosurg; 2013; 23(4):521-6. PubMed ID: 24101275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in malignant glioma. Prognostic factors.
    Phuphanich S; Ferrall S; Greenberg H
    J Fla Med Assoc; 1993 Mar; 80(3):181-4. PubMed ID: 8387566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head trauma and brain tumours revisited.
    Henderson RD; Campbell SF
    J Clin Neurosci; 2000 May; 7(3):262-4. PubMed ID: 10833628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme.
    Vredenburgh JJ; Desjardins A; Kirkpatrick JP; Reardon DA; Peters KB; Herndon JE; Marcello J; Bailey L; Threatt S; Sampson J; Friedman A; Friedman HS
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):58-66. PubMed ID: 21036490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes of giant cell glioblastoma: institutional experience in the management of 20 patients.
    Oh T; Rutkowski MJ; Safaee M; Sun MZ; Sayegh ET; Bloch O; Tihan T; Parsa AT
    J Clin Neurosci; 2014 Dec; 21(12):2129-34. PubMed ID: 25037316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term temozolomide might be an optimal choice for patient with multifocal glioblastoma, especially with deep-seated structure involvement: a case report and literature review.
    Liu Y; Hao S; Yu L; Gao Z
    World J Surg Oncol; 2015 Apr; 13():142. PubMed ID: 25889578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of high-grade astrocytoma.
    Sathornsumetee S; Rich JN; Reardon DA
    Neurol Clin; 2007 Nov; 25(4):1111-39, x. PubMed ID: 17964028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide and treatment of malignant glioma.
    Friedman HS; Kerby T; Calvert H
    Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term experience in high grade glial tumors with temozolomide.
    Demirci U; Buyukberber S; Coskun U; Akmansu M; Yaman E; Baykara M; Yamac D; Uner A; Benekli M
    J BUON; 2012; 17(2):357-62. PubMed ID: 22740218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Difference in the therapeutic efficacy between anaplastic astrocytoma and glioblastoma multiforme types].
    Kiya K; Uozumi T; Kurisu K; Mikami T; Hotta T; Ogasawara H; Sugiyama K; Fujita H
    Gan No Rinsho; 1990 Jun; 36(7):777-81. PubMed ID: 2162401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide.
    Tseng HM; Kuo LT; Lien HC; Liu KL; Liu MT; Huang CY
    Anticancer Drugs; 2010 Nov; 21(10):963-7. PubMed ID: 20838208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.
    Mangla R; Singh G; Ziegelitz D; Milano MT; Korones DN; Zhong J; Ekholm SE
    Radiology; 2010 Aug; 256(2):575-84. PubMed ID: 20529987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
    Aoki T; Mizutani T; Ishikawa M; Sugiyama K; Hashimoto N
    Int J Clin Oncol; 2003 Oct; 8(5):301-4. PubMed ID: 14586755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.
    Reddy K; Damek D; Gaspar LE; Ney D; Waziri A; Lillehei K; Stuhr K; Kavanagh BD; Chen C
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):655-60. PubMed ID: 22483738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.